NasdaqGS - Delayed Quote USD

Utah Medical Products, Inc. (UTMD)

67.16 -0.40 (-0.59%)
At close: April 24 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
50,224.00
50,224.00
52,281.00
49,054.00
42,178.00
Cost of Revenue
20,186.00
20,186.00
20,085.00
18,137.00
16,630.00
Gross Profit
30,038.00
30,038.00
32,196.00
30,917.00
25,548.00
Operating Expense
13,261.00
13,261.00
12,406.00
12,037.00
11,840.00
Operating Income
16,777.00
16,777.00
19,790.00
18,880.00
13,708.00
Other Income Expense
3,312.00
3,312.00
869.00
181.00
132.00
Pretax Income
20,089.00
20,089.00
20,659.00
19,061.00
13,840.00
Tax Provision
3,454.00
3,454.00
4,186.00
4,273.00
3,042.00
Net Income Common Stockholders
16,635.00
16,635.00
16,473.00
14,788.00
10,798.00
Diluted NI Available to Com Stockholders
16,635.00
16,635.00
16,473.00
14,788.00
10,798.00
Basic EPS
4.58
4.58
4.53
4.15
2.96
Diluted EPS
4.57
4.57
4.52
4.04
2.94
Basic Average Shares
3,629.00
3,630.00
3,637.00
3,655.00
3,643.00
Diluted Average Shares
3,637.00
3,637.00
3,643.00
3,660.00
3,672.00
Total Operating Income as Reported
16,777.00
16,777.00
19,790.00
18,880.00
13,708.00
Total Expenses
33,447.00
33,447.00
32,491.00
30,174.00
28,470.00
Net Income from Continuing & Discontinued Operation
16,635.00
16,635.00
16,473.00
14,788.00
10,798.00
Normalized Income
14,121.19
14,121.19
15,946.18
14,659.18
10,710.62
EBIT
16,777.00
16,777.00
19,790.00
18,880.00
13,708.00
EBITDA
23,145.00
23,145.00
26,872.00
26,164.00
20,917.00
Reconciled Cost of Revenue
20,186.00
20,186.00
20,085.00
18,137.00
16,630.00
Reconciled Depreciation
6,368.00
6,368.00
7,082.00
7,284.00
7,209.00
Net Income from Continuing Operation Net Minority Interest
16,635.00
16,635.00
16,473.00
14,788.00
10,798.00
Total Unusual Items Excluding Goodwill
3,036.00
3,036.00
661.00
166.00
112.00
Total Unusual Items
3,036.00
3,036.00
661.00
166.00
112.00
Normalized EBITDA
20,109.00
20,109.00
26,211.00
25,998.00
20,805.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
522.19
522.19
134.18
37.18
24.62
12/31/2020 - 3/8/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MMSI Merit Medical Systems, Inc.
74.03
-0.20%
 
ICUI ICU Medical, Inc.
96.72
-1.06%
 
ATRI Atrion Corporation
424.19
+4.66%
 
ANGO AngioDynamics, Inc.
5.87
-2.65%
 
AZTA Azenta, Inc.
52.09
-0.86%
 
OSUR OraSure Technologies, Inc.
5.50
-0.54%
 
HBIO Harvard Bioscience, Inc.
3.6900
-0.81%
 
ATR AptarGroup, Inc.
140.01
+0.19%
 
HAE Haemonetics Corporation
86.22
+1.35%
 
WST West Pharmaceutical Services, Inc.
385.73
-1.15%